207 related articles for article (PubMed ID: 16251351)
1. Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1.
Srivastava S; Choudhury P; Li Z; Liu G; Nadkarni V; Ko K; Coetzee WA; Skolnik EY
Mol Biol Cell; 2006 Jan; 17(1):146-54. PubMed ID: 16251351
[TBL] [Abstract][Full Text] [Related]
2. Specificity of the myotubularin family of phosphatidylinositol-3-phosphatase is determined by the PH/GRAM domain.
Choudhury P; Srivastava S; Li Z; Ko K; Albaqumi M; Narayan K; Coetzee WA; Lemmon MA; Skolnik EY
J Biol Chem; 2006 Oct; 281(42):31762-9. PubMed ID: 16914545
[TBL] [Abstract][Full Text] [Related]
3. The phosphatidylinositol 3-phosphate phosphatase myotubularin- related protein 6 (MTMR6) is a negative regulator of the Ca2+-activated K+ channel KCa3.1.
Srivastava S; Li Z; Lin L; Liu G; Ko K; Coetzee WA; Skolnik EY
Mol Cell Biol; 2005 May; 25(9):3630-8. PubMed ID: 15831468
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol-3 phosphatase myotubularin-related protein 6 negatively regulates CD4 T cells.
Srivastava S; Ko K; Choudhury P; Li Z; Johnson AK; Nadkarni V; Unutmaz D; Coetzee WA; Skolnik EY
Mol Cell Biol; 2006 Aug; 26(15):5595-602. PubMed ID: 16847315
[TBL] [Abstract][Full Text] [Related]
5. Role of S3 and S4 transmembrane domain charged amino acids in channel biogenesis and gating of KCa2.3 and KCa3.1.
Gao Y; Chotoo CK; Balut CM; Sun F; Bailey MA; Devor DC
J Biol Chem; 2008 Apr; 283(14):9049-59. PubMed ID: 18227067
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the KCa3.1 channel-calmodulin interactions to the regulation of the KCa3.1 gating process.
Morales P; Garneau L; Klein H; Lavoie MF; Parent L; Sauvé R
J Gen Physiol; 2013 Jul; 142(1):37-60. PubMed ID: 23797421
[TBL] [Abstract][Full Text] [Related]
7. Laminar shear stress upregulates endothelial Ca²⁺-activated K⁺ channels KCa2.3 and KCa3.1 via a Ca²⁺/calmodulin-dependent protein kinase kinase/Akt/p300 cascade.
Takai J; Santu A; Zheng H; Koh SD; Ohta M; Filimban LM; Lemaître V; Teraoka R; Jo H; Miura H
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H484-93. PubMed ID: 23792675
[TBL] [Abstract][Full Text] [Related]
8. Histidine phosphorylation of the potassium channel KCa3.1 by nucleoside diphosphate kinase B is required for activation of KCa3.1 and CD4 T cells.
Srivastava S; Li Z; Ko K; Choudhury P; Albaqumi M; Johnson AK; Yan Y; Backer JM; Unutmaz D; Coetzee WA; Skolnik EY
Mol Cell; 2006 Dec; 24(5):665-675. PubMed ID: 17157250
[TBL] [Abstract][Full Text] [Related]
9. Channelopathy of small- and intermediate-conductance Ca
Nam YW; Downey M; Rahman MA; Cui M; Zhang M
Acta Pharmacol Sin; 2023 Feb; 44(2):259-267. PubMed ID: 35715699
[TBL] [Abstract][Full Text] [Related]
10. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.
Oliván-Viguera A; Valero MS; Murillo MD; Wulff H; García-Otín AL; Arbonés-Mainar JM; Köhler R
PLoS One; 2013; 8(3):e58614. PubMed ID: 23516517
[TBL] [Abstract][Full Text] [Related]
11. New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1.
Coleman N; Brown BM; Oliván-Viguera A; Singh V; Olmstead MM; Valero MS; Köhler R; Wulff H
Mol Pharmacol; 2014 Sep; 86(3):342-57. PubMed ID: 24958817
[TBL] [Abstract][Full Text] [Related]
12. Structural Determinants for the Selectivity of the Positive KCa3.1 Gating Modulator 5-Methylnaphtho[2,1-
Brown BM; Shim H; Zhang M; Yarov-Yarovoy V; Wulff H
Mol Pharmacol; 2017 Oct; 92(4):469-480. PubMed ID: 28760780
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological gating modulation of small- and intermediate-conductance Ca(2+)-activated K(+) channels (KCa2.x and KCa3.1).
Christophersen P; Wulff H
Channels (Austin); 2015; 9(6):336-43. PubMed ID: 26217968
[TBL] [Abstract][Full Text] [Related]
14. Role of protein kinase A and class II phosphatidylinositol 3-kinase C2β in the downregulation of KCa3.1 channel synthesis and membrane surface expression by lyso-globotriaosylceramide.
Choi JY; Park S
Biochem Biophys Res Commun; 2016 Feb; 470(4):907-12. PubMed ID: 26820527
[TBL] [Abstract][Full Text] [Related]
15. Histidine phosphorylation relieves copper inhibition in the mammalian potassium channel KCa3.1.
Srivastava S; Panda S; Li Z; Fuhs SR; Hunter T; Thiele DJ; Hubbard SR; Skolnik EY
Elife; 2016 Aug; 5():. PubMed ID: 27542194
[TBL] [Abstract][Full Text] [Related]
16. PKA reduces the rat and human KCa3.1 current, CaM binding, and Ca2+ signaling, which requires Ser332/334 in the CaM-binding C terminus.
Wong R; Schlichter LC
J Neurosci; 2014 Oct; 34(40):13371-83. PubMed ID: 25274816
[TBL] [Abstract][Full Text] [Related]
17. Protein histidine phosphatase 1 negatively regulates CD4 T cells by inhibiting the K+ channel KCa3.1.
Srivastava S; Zhdanova O; Di L; Li Z; Albaqumi M; Wulff H; Skolnik EY
Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14442-6. PubMed ID: 18796614
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the C-terminal four-helix bundle of the potassium channel KCa3.1.
Ji T; Corbalán-García S; Hubbard SR
PLoS One; 2018; 13(6):e0199942. PubMed ID: 29953543
[TBL] [Abstract][Full Text] [Related]
19. The class II phosphatidylinositol 3 kinase C2beta is required for the activation of the K+ channel KCa3.1 and CD4 T-cells.
Srivastava S; Di L; Zhdanova O; Li Z; Vardhana S; Wan Q; Yan Y; Varma R; Backer J; Wulff H; Dustin ML; Skolnik EY
Mol Biol Cell; 2009 Sep; 20(17):3783-91. PubMed ID: 19587117
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs.
Damkjaer M; Nielsen G; Bodendiek S; Staehr M; Gramsbergen JB; de Wit C; Jensen BL; Simonsen U; Bie P; Wulff H; Köhler R
Br J Pharmacol; 2012 Jan; 165(1):223-34. PubMed ID: 21699504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
